394 related articles for article (PubMed ID: 38406978)
1. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.
Kaniecki T; Hughes M; McMahan Z
Expert Rev Clin Immunol; 2024 Jun; 20(6):603-622. PubMed ID: 38406978
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.
Volkmann ER; McMahan Z
Curr Opin Rheumatol; 2022 Nov; 34(6):328-336. PubMed ID: 35993874
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.
Gyger G; Baron M
Curr Rheumatol Rep; 2012 Feb; 14(1):22-9. PubMed ID: 22105546
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis and the gut.
Butt S; Emmanuel A
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal manifestations of systemic sclerosis.
Abu-Shakra M; Guillemin F; Lee P
Semin Arthritis Rheum; 1994 Aug; 24(1):29-39. PubMed ID: 7985035
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis.
McMahan ZH; Tucker AE; Perin J; Volkmann ER; Kulkarni S; Ziessman HA; Pasricha PJ; Wigley FM
Arthritis Care Res (Hoboken); 2022 Mar; 74(3):442-450. PubMed ID: 33064934
[TBL] [Abstract][Full Text] [Related]
8. Acupuncture-based modalities: novel alternative approaches in the treatment of gastrointestinal dysmotility in patients with systemic sclerosis.
Sallam HS; McNearney TA; Chen JD
Explore (NY); 2014; 10(1):44-52. PubMed ID: 24439095
[TBL] [Abstract][Full Text] [Related]
9. Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.
Hansi N; Thoua N; Carulli M; Chakravarty K; Lal S; Smyth A; Herrick A; Ogunbiyi O; Shaffer J; Mclaughlin J; Denton C; Ong V; Emmanuel AV; Murray CD
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-214-21. PubMed ID: 25372804
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.
McMahan ZH; Kulkarni S; Chen J; Chen JZ; Xavier RJ; Pasricha PJ; Khanna D
Nat Rev Rheumatol; 2023 Mar; 19(3):166-181. PubMed ID: 36747090
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal manifestations in Hungarian scleroderma patients.
Szamosi S; Szekanecz Z; Szucs G
Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal involvement in systemic sclerosis: An updated review.
Nassar M; Ghernautan V; Nso N; Nyabera A; Castillo FC; Tu W; Medina L; Ciobanu C; Alfishawy M; Rizzo V; Eskaros S; Mahdi M; Khalifa M; El-Kassas M
Medicine (Baltimore); 2022 Nov; 101(45):e31780. PubMed ID: 36397401
[TBL] [Abstract][Full Text] [Related]
15. Current management of the gastrointestinal complications of systemic sclerosis.
Emmanuel A
Nat Rev Gastroenterol Hepatol; 2016 Aug; 13(8):461-72. PubMed ID: 27381075
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome.
Nguyen AD; Andréasson K; McMahan ZH; Bukiri H; Howlett N; Lagishetty V; Lee SM; Jacobs JP; Volkmann ER
Semin Arthritis Rheum; 2023 Jun; 60():152185. PubMed ID: 36870237
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal Tract Considerations Part I: How Should a Rheumatologist Best Manage Common Upper Gastrointestinal Tract Complaints in Systemic Sclerosis?
Quinlivan A; McMahan ZH; Lee EB; Nikpour M
Rheum Dis Clin North Am; 2023 May; 49(2):295-318. PubMed ID: 37028836
[TBL] [Abstract][Full Text] [Related]
18. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.
Kaniecki T; Abdi T; McMahan ZH
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101666. PubMed ID: 33676855
[TBL] [Abstract][Full Text] [Related]
19. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
[TBL] [Abstract][Full Text] [Related]
20. Measuring response in the gastrointestinal tract in systemic sclerosis.
Khanna D; Nagaraja V; Gladue H; Chey W; Pimentel M; Frech T
Curr Opin Rheumatol; 2013 Nov; 25(6):700-6. PubMed ID: 24047604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
